Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “B-Cell Non-Hodgkin's Lymphoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00101010
What this trial is testing

Rituximab and Combination Chemotherapy in Treating Older Patients With Diffuse Large B-Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 80
Not applicableNot Yet RecruitingNCT06988085
What this trial is testing

Impact of Lymphodepletion Regimen on the Response to CAR T-cells in Patients With With Relapsed/Refractory Large B-cell Lymphoma

Who this might be right for
Large B Cell LymphomaCAR T Cell
Assistance Publique - Hôpitaux de Paris 42
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07744724
What this trial is testing

Pirtobrutinib+Pola-R-CHP for Newly Diagnosed Non-GCB DLBCL

Who this might be right for
DLBCL - Diffuse Large B Cell LymphomaPirtobrutinib
Changzhou No.2 People's Hospital 48
Large-scale testing (Phase 3)Ended earlyNCT00324324
What this trial is testing

Moxifloxacin in Preventing Bacterial Infections in Patients Who Have Undergone Donor Stem Cell Transplant

Who this might be right for
Breast CancerChronic Myeloproliferative DisordersGestational Trophoblastic Tumor+9 more
OHSU Knight Cancer Institute 240
Early research (Phase 1)UnknownNCT02656147
What this trial is testing

Immunotherapy With CD19 CAR γδT-cells for B-Cell Lymphoma, ALL and CLL

Who this might be right for
LeukemiaLymphoma
Beijing Doing Biomedical Co., Ltd. 48
Testing effectiveness (Phase 2)UnknownNCT03261349
What this trial is testing

Antiviral Agent HARVONI® for the Treatment of HCV-associated Indolent B-Cell Lymphoma

Who this might be right for
Indolent Lymphoma
National Taiwan University Hospital 21
Not applicableStudy completedNCT00002485
What this trial is testing

Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer

Who this might be right for
Brain and Central Nervous System TumorsChildhood Germ Cell TumorExtragonadal Germ Cell Tumor+8 more
Children's Oncology Group 359
Testing effectiveness (Phase 2)Looking for participantsNCT06321289
What this trial is testing

Allogeneic TRAC Locus-inserted CD19-targeting STAR T Cell Therapy in r/r B-NHL

Who this might be right for
Non-hodgkin Lymphoma,B Cell
Chinese PLA General Hospital 30
Testing effectiveness (Phase 2)Study completedNCT02529852
What this trial is testing

A Phase I/II Study of Lenalidomide and Obinutuzumab With CHOP for Diffuse Large B Cell Lymphoma

Who this might be right for
Lymphoma
M.D. Anderson Cancer Center 59
Testing effectiveness (Phase 2)WithdrawnNCT03999658
What this trial is testing

STI-3031 (an Anti-PD-L1 Antibody) in Patients With Selected Relapsed/Refractory Malignancies

Who this might be right for
Peripheral T Cell LymphomaDiffuse Large B Cell LymphomaBiliary Tract Cancer+1 more
Sorrento Therapeutics, Inc.
Testing effectiveness (Phase 2)Study completedNCT02600897
What this trial is testing

Obinutuzumab, Polatuzumab Vedotin, and Lenalidomide in Relapsed or Refractory Follicular Lymphoma (FL) and Rituximab in Combination With Polatuzumab Vedotin and Lenalidomide in Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Relapsed or Refractory Follicular Lymphoma, Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Hoffmann-La Roche 114
Testing effectiveness (Phase 2)Study completedNCT03196830
What this trial is testing

CAR-T for R/R B-NHL

Who this might be right for
Relapsed Non Hodgkin LymphomaRefractory Non-Hodgkin LymphomaCAR - T CD19/CD20/CD22/CD30
The First Affiliated Hospital of Soochow University 168
Early research (Phase 1)Study completedNCT00717925
What this trial is testing

Study Evaluating Safety and Tolerability of Inotuzumab Ozogamicin (CMC-544) in Japanese Patients With B-cell Non-Hodgkin's Lymphoma (NHL)

Who this might be right for
Lymphoma, B-Cell
Wyeth is now a wholly owned subsidiary of Pfizer 13
Large-scale testing (Phase 3)Study completedNCT00005590
What this trial is testing

Levofloxacin to Prevent Infection Following Chemotherapy in Treating Patients With Solid Tumors or Lymphoma

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerExtragonadal Germ Cell Tumor+7 more
Cancer Research Campaign Clinical Trials Centre
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07677813
What this trial is testing

Orelabrutinib Combined With Induction Therapy Followed by Sequential Monotherapy Maintenance in MCD Subtype Diffuse Large B-cell Lymphoma

Who this might be right for
DLBCL - Diffuse Large B Cell Lymphoma
Ou Bai, MD/PHD 66
Early research (Phase 1)Study completedNCT04317885
What this trial is testing

A Study Evaluating Safety and Efficacy of C-CAR039 Treatment in NHL Subjects

Who this might be right for
Non-Hodgkin's B-cell Lymphoma
Shanghai Tongji Hospital, Tongji University School of Medicine 25
Testing effectiveness (Phase 2)Study completedNCT00517049
What this trial is testing

PRO95780 in Combination With Rituximab in Patients With Non-Hodgkin's Lymphoma That Has Progressed Following Previous Rituximab Therapy (APM4083g)

Who this might be right for
Non-Hodgkin's Lymphoma
Genentech, Inc. 49
Large-scale testing (Phase 3)Study completedNCT00003650
What this trial is testing

Combination Chemotherapy in Treating Children With Non-Hodgkin's Lymphoma

Who this might be right for
Lymphoma
UNICANCER 179
Testing effectiveness (Phase 2)Ended earlyNCT02530125
What this trial is testing

Pidilizumab in Treating Patients With Stage III-IV Diffuse Large B-Cell Lymphoma Following First Remission

Who this might be right for
Stage III Diffuse Large B-Cell LymphomaStage IV Diffuse Large B-Cell Lymphoma
Northwestern University 4
Early research (Phase 1)Looking for participantsNCT05794958
What this trial is testing

Evaluate Safety of Axicabtagene Ciloleucel Reinfusion (Axi-Cel-2) in Patients With Relapsed and/or Refractory Second Line High-Risk Non-Hodgkin Lymphoma After Standard of Care Axi-Cel

Who this might be right for
Non-Hodgkin LymphomaLarge B-cell Lymphoma
Stanford University 20
Next Page